Associate Medical Director — Early-Phase Drug Development

IQVIA; Newcastle; On-site; AUD 250,000 - 320,000; Full time

Job summary

IQVIA is seeking an Associate Medical Director to lead medical aspects of early phase development across ANZ and APAC. You will provide medical, scientific, strategic, and sponsor-facing input for Phase I/early Phase II trials, ensuring safety, scientific integrity, and compliant study execution.

The ideal candidate will bring strong clinical judgement, early phase drug development experience, and the ability to work with sponsors, investigators, and cross-functional teams in a fast-paced

Qualifications

• Medical degree from an accredited, internationally recognised medical school.
• Current medical licence or eligibility to practise medicine in a recognised jurisdiction.
• Board certification or equivalent specialty training preferred.
• Experience as a Medical Monitor, Associate Medical Director, Medical Advisor, Investigator, or similar role within the pharmaceutical, biotechnology, CRO, or clinical research industry.
• Strong understanding of GCP, ICH guidelines, and applicable clinical research regulations.
• Demonstrated knowledge of drug development and clinical trial conduct.
• Experience in early clinical development, FIH, healthy volunteer, and/or Phase I studies strongly preferred.
• Oncology experience highly advantageous.
• Strong clinical judgement and a pragmatic, risk-based approach to decision-making.
• Effective communicator able to translate complex scientific and medical concepts into practical guidance.
• Proven ability to build trusted relationships with sponsors, investigators, and internal stakeholders.
• Collaborative team player able to work across multidisciplinary and geographically dispersed teams.
• Comfortable in a fast-paced, evolving environment and able to work independently with accountability and sound judgement.
• Passionate about early phase drug development, continuous learning, and contributing to a positive team culture.

Responsibilities

• Serve as the primary Medical Advisor for assigned studies, providing medical oversight throughout the clinical trial lifecycle.
• Act as a scientific partner to sponsors, investigators, and study teams, delivering expert medical guidance and strategic input for early phase development programmes.
• Provide medical support on protocol interpretation, eligibility assessments, safety management, dose escalation decisions, and other protocol-related issues.
• Review and contribute to study protocols, informed consent forms, Investigator's Brochures, case report forms, clinical study reports, patient narratives, and other key study documents.
• Conduct ongoing medical monitoring, including review of adverse events, serious adverse events, emerging safety signals, and clinically significant findings.
• Support SRCs, Dose Escalation Committees, and other governance activities through presentation and interpretation of clinical and safety data.
• Work closely with Pharmacovigilance and project teams on safety evaluations, medical reviews, analysis of similar events, and participant safety activities.
• Deliver therapeutic area and protocol-specific training to project teams, investigators, and study personnel.
• Support protocol development and study design, particularly for FIH, healthy volunteer, and other early phase studies.

Skills

Strong clinical judgement

Effective communicator

Collaborative team player

Relationship building

Stakeholder management

Education

Medical degree

Medical licence eligibility

Board certification preferred

Job description

IQVIA is seeking an Associate Medical Director to lead medical aspects of early phase development across ANZ and APAC. You will provide medical, scientific, strategic, and sponsor-facing input for Phase I/early Phase II trials, ensuring safety, scientific integrity, and compliant study execution.

The ideal candidate will bring strong clinical judgement, early phase drug development experience, and the ability to work with sponsors, investigators, and cross-functional teams in a fast-paced